semaglutide for bariatric patients After Gastric Sleeve: Safety, Timing, and Clinical Guidelines Semaglutide versus placebo in individuals

My take: GLP-1RAs may become more than metabolic drugs, but oncology needs prospective cancer-outcome data before calling this prevention

Autosomal Dominant Polycystic Kidney Disease (ADPKD) leads to end stage kidney disease (ESKD) through the development and expansion of multiple cysts through...

Rocio Salas-Whalen, an expert in obesity medicine, delivers the real-world strategies that have helped thousands of patients achieve health goals that once felt out of reach

A once marginal obesity treatment category is rapidly becoming a $200 billion global market opportunity.

All research compounds include third-party Certificate of Analysis (COA) documentation verifying compound identity, purity 99%, and quality standards for laboratory research

Peptide Sciences semaglutide has caveats despite strong multi-lab purity evidence: two near-threshold purity misses and repeated underfill, including -28%